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pleural thickening might also be diagnosed on the basis of CT
scans.
Compared with pulmonary actinomycosis, the bacteriologic
diagnosis is easily obtained by means of thoracocentesis in case of
pleural involvement. However, diagnosis might be obscured by
previous antibiotic therapy and a lack of anaerobic conditions for
culture. At direct microbiologic examination, actinomycosis has to
be suspected if gram-positive filamentous germs are discovered.
An anaerobic enriched environment is needed for appropriate
culture.
Penicillin G still remains the drug of choice, and the mainstay
of treatment is the administration of high-dose intravenous peni-
cillin. Eighteen to 24 millions units of penicillin per day are given
for 2 to 6 weeks, followed by oral penicillin V administration for
another 6 to 12 months. The evolution should be monitored by use
of plain radiographs or CT.
In stage I empyema, indication for surgical intervention is
uncommon, but the efficacy of antibiotic therapy depends on the
onset of diagnosis. If the treatment is delayed, stage II and III
empyemas can develop, and decortication is required. Chest-wall
fistulization has to be resected during the intervention. A VATS
approach is usually unrewarding because of the chronicity of
empyema at the time of the operation. After the operation, peni-
cillin administration is recommended.
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Thoracic endometriosis: A case report and literature review
Tomasz M. Ziedalski, MD,a,b Viji Sankaranarayanan, MD,a,b and Rajinder K. Chitkara, MD,a,b Palo Alto, Calif
Thoracic endometriosis is a rare disorder characterizedby the presence of functioning endometrial tissue withinthe pleura, the lung parenchyma, or the airways. In thisreport we describe a case of catamenial hemothorax and
review the various presentations, pathogenesis, diagnosis, and
therapies of thoracic endometriosis.
Clinical Summary
A 28-year-old woman was seen for cough, right-sided pleuritic
chest pain, and dyspnea. During the previous 3 years she had had
multiple hospitalizations for right-sided pneumothorax, hemo-
pneumothorax, and hemothorax. She had negative results of a
workup for pulmonary embolism and of a pleural biopsy. The
symptoms occurred within 24 to 48 hours after the onset of
menses. Danazol therapy was unsuccessful and she refused hys-
terectomy with oophorectomy. Examination revealed a pale,
mildly dyspneic woman with decreased breath sounds at the right
base of the lungs. Chest radiography demonstrated a right-sided
air-fluid level. Thoracentesis drained hemorrhagic fluid. Culture
results were negative, and cytologic examination demonstrated
endometrial epithelial cells with no evidence of malignancy. The
postthoracentesis chest radiograph showed a small rounded pleural
density and gas-liquid level on the right side. The patient subse-
quently underwent pleurectomy, with removal of the pleural im-
plant (Figures 1 and 2) and talc pleurodesis. One year later, she
was free of symptoms.
Discussion
Thoracic endometriosis is a rare disorder with varying clinical
presentations. The largest series reviewed 112 cases of thoracic
pathology associated with menstruation presenting as hemoptysis,
hemothorax, pneumothorax, or pulmonary nodules.1 The term
thoracic endometriosis syndrome (TES) was proposed. The mean
age at diagnosis was 35 years, with a range from 19 to 54 years.
Pneumothorax occurred in 73% of the cases, hemothorax in 14%,
hemoptysis in 7%, and nodules in 6%. Patients had chest pain in
90% of the cases and dyspnea in 31%. In 90% of patients, the
symptoms occurred within 2 days after the onset of menstruation.
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The diagnosis of TES is challenging, and it is often delayed
until the symptoms’ temporal relationship with menses is recog-
nized. Chest radiographic findings are nonspecific and vary with
menstrual cycle. Catamenial pneumothoraces and hemothoraces
are typically unilateral and predominantly right sided.1 Computed
tomographic findings include opacities, nodular lesions, thin-
walled cavities, and bullous formations.2 Pleural fluid cytologic
examination is rarely helpful. The utility of bronchoscopy is lim-
ited, because most cases of TES involve the distal parenchyma. In
tracheobronchial endometriosis, multiple friable, purplish-red,
submucosal patches may be seen. Surgery is frequently needed to
establish the diagnosis, and more than 60% of affected patients
require thoracotomy or thoracoscopy as part of diagnostic ap-
proach.1
The pathogenesis of TES remains elusive. Three different the-
ories have been proposed3: migration of air through the uterus and
Fallopian tubes into the abdomen and through diaphragmatic fen-
estrations into the thorax; endometrial tissue microembolization;
and high levels of serum prostaglandins causing vasospasm and
bronchospasm, thus resulting in alveolar rupture and a pneumo-
thorax.
The most effective treatment strategy remains controversial
because of the anecdotal nature of reports of the disorder and lack
of therapeutic trials. Medical approaches focus on the suppression
of endometrial tissue by blocking the action of estrogen. Although
oral contraceptives, progesterone, and danazol have been noted to
be effective in anecdotal reports, recurrence rates greater than 50%
have been reported.1 The high failure rates may be due to incom-
plete suppression of thoracic endometrial tissue and recurrent
embolization from pelvic foci. Hormonal manipulation may be
unacceptable to some women, because it precludes pregnancy.
Furthermore, virilization, weight gain, and climacteric symptoms
make hormonal therapy a less attractive option.4
Hysterectomy with bilateral salpingo-oophorectomy remains
the definitive treatment for TES, but it may be ineffective for
patients receiving estrogen replacement therapy, which may reac-
tivate thoracic endometrial tissue.5 Chemical pleurodesis has been
shown to be effective in the treatment of TES complicated by
hemothorax or pneumothorax. It can be achieved by tube thora-
costomy with the application of talc or doxycycline or by thora-
coscopic pleural abrasion and partial pleurectomy. In patients with
a chronic and a relatively benign course of the disease, chemical
pleurodesis is recommended before more aggressive surgical pro-
cedures.
Lung-sparing segmentectomy or wedge resection can be poten-
tially curative.4 Because of its invasive nature and associated
morbidity, however, surgery has not been generally used as a first
line of approach. It is limited to patients with a single focus of
thoracic endometrial tissue or foci confined to a small area where
a tissue-sparing procedure can be performed. Careful evaluation
with chest computed tomography is therefore essential before
patient selection. When nodules are multiple or not detected,
hormonal therapy should be considered.
Video-assisted thoracoscopic surgery has become a safer and
less invasive method of therapy. The bleeding lesions in the lung
can be visualized clearly with video-assisted thoracoscopic sur-
gery. Partial resection with the removal of all pigmented lesions by
video-assisted thoracoscopic surgery can be effective in the treat-
ment of TES.6 This modality, however, requires evaluation in
larger patient series.
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Figure 1. Removed pleural implant (exterior).
Figure 2. Removed pleural implant (interior).
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